5//SEC Filing
10X Fund, L.P. 5
Accession 0001493152-25-017839
CIK 0001133416other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 6:27 PM ET
Size
9.2 KB
Accession
0001493152-25-017839
Insider Transaction Report
Form 5
10X Fund, L.P.
10% Owner
Transactions
- Sale
Common Stock
2024-04-22$3.06/sh−21,323$65,248→ 5,925,884 total(indirect: By 10X Fund, LP) - Sale
Common Stock
2024-04-23$3.06/sh−3,677$11,252→ 5,922,207 total(indirect: By 10X Fund, LP)
10X Capital Management, LLC
10% Owner
Transactions
- Sale
Common Stock
2024-04-22$3.06/sh−21,323$65,248→ 5,925,884 total(indirect: By 10X Fund, LP) - Sale
Common Stock
2024-04-23$3.06/sh−3,677$11,252→ 5,922,207 total(indirect: By 10X Fund, LP)
Footnotes (1)
- [F1]10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001453356
Filing Metadata
- Form type
- 5
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 6:27 PM ET
- Size
- 9.2 KB